At ichorbio, we are passionate about animals and believe there is a better way to do in vivo research. For us, the most important consideration was that our antibodies for in vivo use have the lowest possible impact on the animals they are being used in. This is how our mission was born: to create the best antibodies for in vivo research. To achieve our mission, we have created products that have lower endotoxin, higher purity and lower aggregation than other antibodies currently available on the market. Our antibodies adhere to all the same criteria as many of the larger manufacturers from a quality perspective with the added benefit that you can feel confident that you are doing the best for your animals. Best selling antibodies: RMP1-14: https://ichor.bio/ich1132-compared-to-be0146 RMP1-14 LALAPG: https://ichor.bio/revolutionize-your-pd-1-research-with-rmp1-14-lalapg
| Website | http://www.ichor.bio |
| Employees | 3 (3 on RocketReach) |
| Founded | 2019 |
| Phone | +44 1235 644626 |
| Technologies | |
| Industry | Biotechnology |
| Keywords | In Vivo Research, Antibody Development, Animal Research, Research Antibodies, Therapeutic Antibodies, Preclinical Research, Animal Welfare, In Vivo Models, Biotechnology, Drug Discovery, Laboratory Animals, Pharmaceutical Research, Immunology Research, Biomedical Research, Biotechnology Solutions, Therapeutic Development, Life Sciences, Scientific Research, Precision Medicine |
Looking for a particular ichorbio employee's phone or email?
James Taylor-Mosedale is the Co-Founder of ichorbio.
3 people are employed at ichorbio.
ichorbio is based in Oxford, England.